IMMUNOHISTOCHEMICAL EXAMINATION OF SKIN WOUNDS WITH ANTIBODIES AGAINST ALPHA-1-ANTICHYMOTRYPSIN, ALPHA-2-MACROGLOBULIN AND LYSOZYME

被引:9
作者
FIEGUTH, A
KLEEMANN, WJ
TROGER, HD
机构
[1] Institut für Rechtsmedizin, Medizinische Hochschule Hannover, Hannover, D-30625
关键词
ALPHA-1-ANTICHYMOTRYPSIN; ALPHA-2-MACROGLOBULIN; LYSOZYME; IMMUNOHISTOCHEMISTRY; WOUND AGE;
D O I
10.1007/BF01247271
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The distribution of the proteinase inhibitors alpha-1-antichymotrypsin (alpha 1-act), alpha-2-macroglobulin (alpha-2-m) and lysozyme was analysed immunohistochemically in 27 intravitally acquired wounds, 3 postmortem skin lacerations and 9 specimens of undamaged skin. Intravitally acquired wounds demonstrated distinct positive reactions for all antibodies examined (alpha-1-act 66.6%; alpha-2-m 51.9%; lysozyme 25.9%). However the undamaged skin margins opposite the wound margins also gave positive reactions (alpha-1-act 51.8%; alpha-2-m 37.0%; lysozyme 25.9%). Nearly half of the control cases (specimens of undamaged skin) exhibited weak positive reactions for all 3 antibodies. These could be easily distinguished from the strong positive reactions observed in intravitally acquired wounds. False positive reactions were observed due to contamination resulting from contact with serum components, in cases of advanced autolysis of specimens, and as a result of fixation and drying artefacts. Even though immunohistochemical studies of alpha-1-act, alpha-2-m and lysozyme give some indications concerning wound vitality, they cannot be considered as proof because irrefutable differentiation of true positive and false positive reactions is not possible in all cases.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 13 条
[1]  
BERNIGER RW, 1986, J MED EXP CLIN, V16, P101
[2]   IMMUNOHISTOCHEMICAL LOCALIZATION OF FIBRONECTIN AS A TOOL FOR THE AGE-DETERMINATION OF HUMAN SKIN WOUNDS [J].
BETZ, P ;
NERLICH, A ;
WILSKE, J ;
TUBEL, J ;
WIEST, I ;
PENNING, R ;
EISENMENGER, W .
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 1992, 105 (01) :21-26
[3]  
DANIELS JC, 1974, SERUM PROTEIN ABNORM, P243
[4]  
FECHNER G, 1994, IN PRESS INT J LEG M
[5]  
HEIMBURGER N, 1972, PULMONARY EMPHYSEMA, P307
[6]  
LAURELL CB, 1972, PULMONARY EMPHYSEMA, P161
[7]  
MOTOI M, 1980, VIRCHOWS ARCH B, V35, P73, DOI 10.1007/BF02889150
[8]  
Nathrath W B, 1982, Acta Histochem Suppl, V25, P69
[9]  
OEHMICHEN M, 1989, Z RECHTSMED, V102, P461
[10]  
ROBERTS RC, 1986, J MED, V16, P129